{
  "4906580": "EBUS PROCEDURE NOTE\nDate: [REDACTED]\nPatient: [REDACTED] | MRN: [REDACTED] | Age: 71M\nAttending: Dr. Christine Lee, MD\nCytopathologist: Dr. Mark Thompson, MD\nLocation: [REDACTED]\n\nINDICATION: 71M with 3.5cm RUL mass (SUV 12), PET-positive mediastinal nodes (4R, 7). EBUS for staging prior to treatment planning.\n\nPROCEDURE: EBUS-TBNA\n\nANESTHESIA: Moderate sedation\n\nRESULTS:\n\nStation 4R (Right lower paratracheal):\n- 20mm, heterogeneous, no CHS\n- 4 passes with 22G needle\n- ROSE: POSITIVE - Adenocarcinoma\n\nStation 7 (Subcarinal):\n- 24mm, round, heterogeneous\n- 4 passes\n- ROSE: POSITIVE - Adenocarcinoma\n\nStation 11R (Right interlobar):\n- 12mm\n- 3 passes\n- ROSE: POSITIVE - Adenocarcinoma\n\nSpecimens sent for cell block, molecular testing (EGFR, ALK, ROS1, PD-L1).\n\nIMPRESSION: EBUS-TBNA confirms metastatic adenocarcinoma at stations 4R, 7, 11R. Pathologic N2 disease. Stage IIIA (cT2aN2M0).\n\nPLAN: Medical oncology referral for concurrent chemoradiation.\n\nDr. Christine Lee, MD"
}
